Skip to main content
Santhera Pharmaceuticals Holding AG (LON:0QN1)
London flag London · Delayed Price · Currency is GBP · Price in CHF
12.18
+0.58 (5.00%)
At close: Jun 20, 2025

LON:0QN1 Revenue

In the year 2024, Santhera Pharmaceuticals Holding AG had annual revenue of 39.12M CHF, down -62.17%. Santhera Pharmaceuticals Holding AG had revenue of 25.00M in the half year ending December 31, 2024, with 1,944.40% growth.

Revenue
39.12M CHF
Revenue Growth
-62.17%
P/S Ratio
4.16
Revenue / Employee
498.31K CHF
Employees
79
Market Cap
143.60M GBP

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202439.12M-64.30M-62.17%
Dec 31, 2023103.41M95.94M1,283.84%
Dec 31, 20227.47M9.07M-568.53%
Dec 31, 2021-1.60M-16.60M-110.63%
Dec 31, 202015.01M-60.37M-80.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Indivior 905.57M
Revenue Rankings

Santhera Pharmaceuticals Holding AG News

More News